Logo

IP Update: Recent Patents Awarded to UC Oakland, Merck

Feb 13, 2014
Premium

Title: Prevention of Chlamydia Infection using siRNA

Patent Number: 8,648,052

Filed: Oct. 8, 2007

Lead Inventor: Jonathan Braun, University of California, Oakland

Title: RNA Interference-mediated Inhibition of Gene Expression using Chemically Modified Short Interfering Nucleic Acid

Patent Number: 8,648,185

Filed: May 15, 2012

Lead Inventor: James McSwiggen, Merck

Filed under

Gene Editing, Gene Silencing, & CRISPR
Business News
RNAi
intellectual property
USPTO
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.